增加的赫索胺生物合成路径流量会改变INS-1E细胞和小鼠群岛的细胞-细胞粘附
Dario Domenico Lofrumento1, Alessandro Miraglia1, Velia La Pesa2
1DiSTeBA, Centro Ecotekne, Strada Monteroni, University of Salento, 73100, Lecce, Italy.
Endocrine
|June 12, 2023
概括
增加的六胺通路流量会通过改变E-cadherin的局部化而损害β细胞相互作用,影响细胞粘附和岛屿结构. 这揭示了在2型糖尿病中控制葡萄糖毒性的新目标.
科学领域:
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
- 糖尿病研究 糖尿病研究
背景情况:
- 2型糖尿病涉及β细胞衰竭,其特征是亡和功能障碍.
- 与赫索胺生物合成途径相关的葡萄糖毒性,有助于β细胞死亡.
- 贝塔细胞通信 (同型相互作用) 对胰岛素分泌和小岛功能至关重要.
研究的目的:
- 为了研究如何增加赫索胺生物合成途径的流量影响β细胞-β细胞相互作用.
- 确定E-cadherin和β-catenin在调解这些效应中的作用.
- 探索葡萄糖毒性诱导的β细胞功能障碍的潜在治疗点.
主要方法:
- 在实验中利用了INS-1E细胞和小鼠群岛.
- 评估了E-cadherin和β-catenin的表达和局部化,通过免疫光学,免疫组织化学和西部斑.
- 通过显微观观测,通过悬浮滴聚合试验和小岛架构评估细胞-细胞粘附.
主要成果:
- 增加的六胺通路流量导致细胞表面E-cadherin减少和细胞内E-cadherin增加,从戈尔吉到ER的局部性改变.
- β-catenin从血转移到细胞质中,反映了E-cadherin的变化.
- 在INS-1E细胞中,聚合率降低,而ex vivo岛屿显示结构改变和表面减少E-cadherin/β-catenin.
结论:
- 升高的六胺通路流动会破坏β细胞中的E-cadherin定位,损害细胞-细胞粘附和岛屿形态.
- 在E-cadherin功能中的这些变化代表了一种新的机制,有助于葡萄糖毒性.
- 针对这些E-cadherin介导的变化提供了一种潜在的策略,以减轻2型糖尿病中的β细胞损伤.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K


